#begin document (en_1080.txt); part 000
en_1080.txt	0	0	Drugstore	NNP	(TOP(NP*	-	-	-	-	*	-
en_1080.txt	0	1	Geneticist	NNP	*))	-	-	-	-	*	-

en_1080.txt	0	0	LA	NNP	(TOP(S(X*	-	-	-	-	*	-
en_1080.txt	0	1	JOLLA	NNP	*	-	-	-	-	*	-
en_1080.txt	0	2	,	,	*	-	-	-	-	*	-
en_1080.txt	0	3	CALIFORNIA	NNP	*	-	-	-	-	*	-
en_1080.txt	0	4	–	SYM	(X*)	-	-	-	-	*	-
en_1080.txt	0	5	Back	NNP	*)	-	-	-	-	*	-
en_1080.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	7	June	NNP	(NP*	-	-	-	-	*	-
en_1080.txt	0	8	2000	CD	*))	-	-	-	-	*	-
en_1080.txt	0	9	,	,	*	-	-	-	-	*	-
en_1080.txt	0	10	when	WRB	(SBAR(WHADVP*)	-	-	-	-	*	-
en_1080.txt	0	11	the	DT	(S(NP*	-	-	-	-	*	(0
en_1080.txt	0	12	draft	NN	*	-	-	-	-	*	-
en_1080.txt	0	13	human-genome	JJ	*	-	-	-	-	*	-
en_1080.txt	0	14	sequence	NN	*)	-	-	-	-	*	0)
en_1080.txt	0	15	was	VBD	(VP*	-	-	-	-	*	-
en_1080.txt	0	16	announced	VBN	(VP*))))	-	-	-	-	*	-
en_1080.txt	0	17	,	,	*	-	-	-	-	*	-
en_1080.txt	0	18	US	NNP	(NP*	-	-	-	-	*	-
en_1080.txt	0	19	President	NNP	*	-	-	-	-	*	-
en_1080.txt	0	20	Bill	NNP	*	-	-	-	-	*	-
en_1080.txt	0	21	Clinton	NNP	*)	-	-	-	-	*	-
en_1080.txt	0	22	proclaimed	VBD	(VP*	-	-	-	-	*	-
en_1080.txt	0	23	,	,	*	-	-	-	-	*	-
en_1080.txt	0	24	``	``	*	-	-	-	-	*	-
en_1080.txt	0	25	It	PRP	(S(NP*)	-	-	-	-	*	(0)
en_1080.txt	0	26	will	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	27	revolutionize	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	28	the	DT	(NP(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	29	diagnosis	NN	*)	-	-	-	-	*	-
en_1080.txt	0	30	,	,	*	-	-	-	-	*	-
en_1080.txt	0	31	prevention	NN	(NP*)	-	-	-	-	*	-
en_1080.txt	0	32	,	,	*	-	-	-	-	*	-
en_1080.txt	0	33	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	34	treatment	NN	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	35	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	36	most	JJS	(NP*))))	-	-	-	-	*	-
en_1080.txt	0	37	,	,	(PRN*	-	-	-	-	*	-
en_1080.txt	0	38	if	IN	(SBAR*	-	-	-	-	*	-
en_1080.txt	0	39	not	RB	(FRAG*	-	-	-	-	*	-
en_1080.txt	0	40	all	DT	(NP*)))	-	-	-	-	*	-
en_1080.txt	0	41	,	,	*)	-	-	-	-	*	-
en_1080.txt	0	42	human	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	43	diseases	NNS	*))))))	-	-	-	-	*	-
en_1080.txt	0	44	.	.	*	-	-	-	-	*	-
en_1080.txt	0	45	''	''	*))	-	-	-	-	*	-

en_1080.txt	0	0	A	DT	(TOP(S(ADVP(NP*	-	-	-	-	*	-
en_1080.txt	0	1	decade	NN	*)	-	-	-	-	*	-
en_1080.txt	0	2	later	RB	*)	-	-	-	-	*	-
en_1080.txt	0	3	,	,	*	-	-	-	-	*	-
en_1080.txt	0	4	hope	NN	(NP*)	-	-	-	-	*	-
en_1080.txt	0	5	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	given	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	7	way	NN	(NP(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	8	to	TO	(PP*	-	-	-	-	*	-
en_1080.txt	0	9	disappointment	NN	(NP*)))	-	-	-	-	*	-
en_1080.txt	0	10	,	,	*	-	-	-	-	*	-
en_1080.txt	0	11	reflected	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	13	headlines	NNS	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	14	like	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	15	``	``	*	-	-	-	-	*	-
en_1080.txt	0	16	Gene	NNP	(NP*	-	-	-	-	*	-
en_1080.txt	0	17	Map	NNP	*	-	-	-	-	*	-
en_1080.txt	0	18	Yields	NNS	*	-	-	-	-	*	-
en_1080.txt	0	19	Few	JJ	*	-	-	-	-	*	-
en_1080.txt	0	20	New	NNP	*	-	-	-	-	*	-
en_1080.txt	0	21	Cures	NNPS	*))))))))	-	-	-	-	*	-
en_1080.txt	0	22	.	.	*	-	-	-	-	*	-
en_1080.txt	0	23	''	''	*))	-	-	-	-	*	-

en_1080.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1080.txt	0	1	pessimism	NN	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	2	about	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	4	potential	NN	*)	-	-	-	-	*	-
en_1080.txt	0	5	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	6	human-genome	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	7	research	NN	*))	-	-	-	-	*	-
en_1080.txt	0	8	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_1080.txt	0	9	yield	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	10	medical	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	11	breakthroughs	NNS	*))))))))	-	-	-	-	*	-
en_1080.txt	0	12	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	13	arisen	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	14	from	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	15	unrealistic	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	16	expectations	NNS	*))))	-	-	-	-	*	-
en_1080.txt	0	17	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Indeed	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	1	,	,	*	-	-	-	-	*	-
en_1080.txt	0	2	while	IN	(SBAR*	-	-	-	-	*	-
en_1080.txt	0	3	``	``	(S(NP*	-	-	-	-	*	-
en_1080.txt	0	4	silver	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	5	bullets	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	6	''	''	*	-	-	-	-	*	-
en_1080.txt	0	7	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	8	can	MD	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	9	cure	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	10	our	PRP$	(NP*	-	-	-	-	*	(1)
en_1080.txt	0	11	most	RBS	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	12	feared	VBN	*)	-	-	-	-	*	-
en_1080.txt	0	13	diseases	NNS	*))))))	-	-	-	-	*	-
en_1080.txt	0	14	have	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	15	not	RB	*	-	-	-	-	*	-
en_1080.txt	0	16	been	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	17	found	VBN	(VP*)))))	-	-	-	-	*	-
en_1080.txt	0	18	,	,	*	-	-	-	-	*	-
en_1080.txt	0	19	progress	NN	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	20	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	21	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	22	area	NN	*)	-	-	-	-	*	-
en_1080.txt	0	23	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	24	gene-drug	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	25	interactions	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	26	,	,	*	-	-	-	-	*	-
en_1080.txt	0	27	known	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	28	as	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	29	pharmacogenomics	NNS	(NP*)))	-	-	-	-	*	-
en_1080.txt	0	30	,	,	*)))))	-	-	-	-	*	-
en_1080.txt	0	31	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	32	been	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	33	extraordinary	JJ	(ADJP*)))	-	-	-	-	*	-
en_1080.txt	0	34	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1080.txt	0	1	ability	NN	*	-	-	-	-	*	-
en_1080.txt	0	2	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	3	determine	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	5	principal	JJ	*	-	-	-	-	*	-
en_1080.txt	0	6	genes	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	7	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	8	account	VBP	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	9	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	10	our	PRP$	(NP(NP*	-	-	-	-	*	(1)
en_1080.txt	0	11	variable	JJ	*	-	-	-	-	*	-
en_1080.txt	0	12	response	NN	*)	-	-	-	-	*	-
en_1080.txt	0	13	to	TO	(PP*	-	-	-	-	*	-
en_1080.txt	0	14	prescription	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	15	drugs	NNS	*))))))))))))	-	-	-	-	*	-
en_1080.txt	0	16	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	17	been	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	18	advanced	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	19	by	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	20	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	21	technique	NN	*)	-	-	-	-	*	-
en_1080.txt	0	22	known	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	23	as	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	24	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	25	genome-wide	JJ	*	-	-	-	-	*	-
en_1080.txt	0	26	association	NN	*	-	-	-	-	*	-
en_1080.txt	0	27	study	NN	*)))	-	-	-	-	*	-
en_1080.txt	0	28	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1080.txt	0	29	GWAS	NNP	(NP*)	-	-	-	-	*	-
en_1080.txt	0	30	-RRB-	-RRB-	*))))))	-	-	-	-	*	-
en_1080.txt	0	31	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	The	DT	(TOP(S(S(NP*	-	-	-	-	*	(2
en_1080.txt	0	1	whole	JJ	*	-	-	-	-	*	-
en_1080.txt	0	2	human	JJ	*	-	-	-	-	*	-
en_1080.txt	0	3	genome	NN	*)	-	-	-	-	*	2)
en_1080.txt	0	4	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	5	approximately	RB	(NP(QP*	-	-	-	-	*	-
en_1080.txt	0	6	six	CD	*	-	-	-	-	*	-
en_1080.txt	0	7	billion	CD	*)	-	-	-	-	*	-
en_1080.txt	0	8	bases	NNS	*)))	-	-	-	-	*	-
en_1080.txt	0	9	,	,	*	-	-	-	-	*	-
en_1080.txt	0	10	but	CC	*	-	-	-	-	*	-
en_1080.txt	0	11	a	DT	(S(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	12	window	NN	*)	-	-	-	-	*	-
en_1080.txt	0	13	into	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	14	its	PRP$	(NP*	-	-	-	-	*	(2)
en_1080.txt	0	15	composition	NN	*)))	-	-	-	-	*	-
en_1080.txt	0	16	can	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	17	be	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	18	probed	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	19	using	VBG	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	20	approximately	RB	(NP(NP(QP*	-	-	-	-	*	-
en_1080.txt	0	21	one	CD	*	-	-	-	-	*	-
en_1080.txt	0	22	million	CD	*)	-	-	-	-	*	-
en_1080.txt	0	23	bases	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	24	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1080.txt	0	25	0.01	CD	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	26	%	NN	*)	-	-	-	-	*	-
en_1080.txt	0	27	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	28	the	DT	(NP*	-	-	-	-	*	(2
en_1080.txt	0	29	genome	NN	*)))	-	-	-	-	*	2)
en_1080.txt	0	30	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1080.txt	0	31	via	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	32	a	DT	(NP*	-	-	-	-	*	(3
en_1080.txt	0	33	gene	NN	*	-	-	-	-	*	-
en_1080.txt	0	34	chip	NN	*))))))))	-	-	-	-	*	3)
en_1080.txt	0	35	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	(4
en_1080.txt	0	1	bases	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	2	on	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	3	the	DT	(NP*	-	-	-	-	*	(3
en_1080.txt	0	4	chip	NN	*)))	-	-	-	-	*	4)|3)
en_1080.txt	0	5	are	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	selected	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	7	because	IN	(SBAR*	-	-	-	-	*	-
en_1080.txt	0	8	they	PRP	(S(NP*)	-	-	-	-	*	(4)
en_1080.txt	0	9	are	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	10	informative	JJ	(ADJP*)	-	-	-	-	*	-
en_1080.txt	0	11	,	,	*	-	-	-	-	*	-
en_1080.txt	0	12	tagging	VBG	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	13	bins	NNS	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	14	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	15	the	DT	(NP*	-	-	-	-	*	(2
en_1080.txt	0	16	genome	NN	*)))))	-	-	-	-	*	2)
en_1080.txt	0	17	,	,	*	-	-	-	-	*	-
en_1080.txt	0	18	like	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	19	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	20	post-code	JJ	*	-	-	-	-	*	-
en_1080.txt	0	21	directory	NN	*)))))))	-	-	-	-	*	-
en_1080.txt	0	22	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Using	VBG	(TOP(S(S(VP*	-	-	-	-	*	-
en_1080.txt	0	1	GWAS	NNP	(NP*	-	-	-	-	*	-
en_1080.txt	0	2	methodology	NN	*)))	-	-	-	-	*	-
en_1080.txt	0	3	,	,	*	-	-	-	-	*	-
en_1080.txt	0	4	we	PRP	(NP*)	-	-	-	-	*	(1)
en_1080.txt	0	5	have	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	learned	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	8	biological	JJ	*	-	-	-	-	*	-
en_1080.txt	0	9	basis	NN	*)	-	-	-	-	*	-
en_1080.txt	0	10	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	11	responses	NNS	(NP*))	-	-	-	-	*	-
en_1080.txt	0	12	to	TO	(PP*	-	-	-	-	*	-
en_1080.txt	0	13	many	JJ	(NP*	-	-	-	-	*	(5
en_1080.txt	0	14	drugs	NNS	*))	-	-	-	-	*	5)
en_1080.txt	0	15	–	SYM	(X(X*)	-	-	-	-	*	-
en_1080.txt	0	16	both	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	17	their	PRP$	(NP*	-	-	-	-	*	(5)
en_1080.txt	0	18	effectiveness	NN	*)	-	-	-	-	*	-
en_1080.txt	0	19	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	20	important	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	21	side-effects	NNS	*))))))	-	-	-	-	*	-
en_1080.txt	0	22	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Examples	NNS	(TOP(S(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	1	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	2	this	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	3	progress	NN	*))	-	-	-	-	*	-
en_1080.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	5	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	6	past	JJ	*	-	-	-	-	*	-
en_1080.txt	0	7	couple	NN	*)	-	-	-	-	*	-
en_1080.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	9	years	NNS	(NP*)))))	-	-	-	-	*	-
en_1080.txt	0	10	are	VBP	(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	11	plentiful	JJ	(ADJP*))	-	-	-	-	*	-
en_1080.txt	0	12	,	,	*	-	-	-	-	*	-
en_1080.txt	0	13	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	14	include	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	15	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	16	statins	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	17	,	,	*	-	-	-	-	*	-
en_1080.txt	0	18	Plavix	NNP	(NP*)	-	-	-	-	*	(6)
en_1080.txt	0	19	,	,	*	-	-	-	-	*	-
en_1080.txt	0	20	interferon	NN	(NP*)	-	-	-	-	*	-
en_1080.txt	0	21	,	,	*	-	-	-	-	*	-
en_1080.txt	0	22	warfarin	NN	(NP*)	-	-	-	-	*	-
en_1080.txt	0	23	,	,	*	-	-	-	-	*	-
en_1080.txt	0	24	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	25	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	26	antibiotic	JJ	*	-	-	-	-	*	-
en_1080.txt	0	27	flucloxacillin	NN	*))))	-	-	-	-	*	-
en_1080.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	The	DT	(TOP(S(S(NP(NP*	-	-	-	-	*	(7
en_1080.txt	0	1	main	JJ	*	-	-	-	-	*	-
en_1080.txt	0	2	side-effect	NN	*)	-	-	-	-	*	-
en_1080.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	4	statins	NNS	(NP*))	-	-	-	-	*	-
en_1080.txt	0	5	,	,	*	-	-	-	-	*	-
en_1080.txt	0	6	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	7	lower	VBP	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	8	cholesterol	NN	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	9	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	10	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	11	blood	NN	*))))))	-	-	-	-	*	-
en_1080.txt	0	12	,	,	*)	-	-	-	-	*	7)
en_1080.txt	0	13	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	14	severe	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	15	muscle	NN	*	-	-	-	-	*	-
en_1080.txt	0	16	inflammation	NN	*)))	-	-	-	-	*	-
en_1080.txt	0	17	,	,	*	-	-	-	-	*	-
en_1080.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	19	it	PRP	(S(NP*)	-	-	-	-	*	(7)
en_1080.txt	0	20	can	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	21	now	RB	(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	22	be	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	23	predicted	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	24	with	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	25	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	26	simple	JJ	*	-	-	-	-	*	-
en_1080.txt	0	27	genotype	JJ	*	-	-	-	-	*	-
en_1080.txt	0	28	test	NN	*))	-	-	-	-	*	-
en_1080.txt	0	29	,	,	*	-	-	-	-	*	-
en_1080.txt	0	30	as	IN	(SBAR*	-	-	-	-	*	-
en_1080.txt	0	31	can	MD	(SINV*	-	-	-	-	*	-
en_1080.txt	0	32	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	33	response	NN	*)	-	-	-	-	*	-
en_1080.txt	0	34	to	TO	(PP*	-	-	-	-	*	-
en_1080.txt	0	35	Plavix	NNP	(NP(NP*)	-	-	-	-	*	(6)
en_1080.txt	0	36	,	,	*	-	-	-	-	*	-
en_1080.txt	0	37	the	DT	(NP*	-	-	-	-	*	(8
en_1080.txt	0	38	second	JJ	*	-	-	-	-	*	-
en_1080.txt	0	39	most	RBS	(ADJP(ADVP*	-	-	-	-	*	-
en_1080.txt	0	40	commonly	RB	*)	-	-	-	-	*	-
en_1080.txt	0	41	prescribed	VBN	*)	-	-	-	-	*	-
en_1080.txt	0	42	drug	NN	*))))	-	-	-	-	*	8)
en_1080.txt	0	43	after	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	44	statins	NNS	(NP*))))))))	-	-	-	-	*	-
en_1080.txt	0	45	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Those	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	1	individuals	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	2	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	3	carry	VBP	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	4	at	IN	(NP(NP(QP*	-	-	-	-	*	-
en_1080.txt	0	5	least	JJS	*	-	-	-	-	*	-
en_1080.txt	0	6	one	CD	*)	-	-	-	-	*	-
en_1080.txt	0	7	copy	NN	*)	-	-	-	-	*	-
en_1080.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	9	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	10	gene	NN	*	-	-	-	-	*	-
en_1080.txt	0	11	variant	NN	*)	-	-	-	-	*	-
en_1080.txt	0	12	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	13	does	VBZ	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	14	not	RB	*	-	-	-	-	*	-
en_1080.txt	0	15	allow	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	16	the	DT	(S(NP*	-	-	-	-	*	-
en_1080.txt	0	17	body	NN	*)	-	-	-	-	*	-
en_1080.txt	0	18	to	TO	(VP*	-	-	-	-	*	-
en_1080.txt	0	19	metabolize	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	20	Plavix	NNP	(NP*)))))))))))))))	-	-	-	-	*	(6)
en_1080.txt	0	21	have	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	22	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	23	300	CD	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	24	%	NN	*)	-	-	-	-	*	-
en_1080.txt	0	25	higher	JJR	*	-	-	-	-	*	-
en_1080.txt	0	26	risk	NN	*)	-	-	-	-	*	-
en_1080.txt	0	27	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	28	clotting	VBG	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	29	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	30	stent	NN	*))))))	-	-	-	-	*	-
en_1080.txt	0	31	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	This	DT	(TOP(S(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	1	variation	NN	*)	-	-	-	-	*	-
en_1080.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	3	the	DT	(NP*	-	-	-	-	*	(2
en_1080.txt	0	4	genome	NN	*)))	-	-	-	-	*	2)
en_1080.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	exceptionally	RB	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	7	common	JJ	*)	-	-	-	-	*	-
en_1080.txt	0	8	,	,	*	-	-	-	-	*	-
en_1080.txt	0	9	present	JJ	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	10	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	11	30	CD	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	12	%	NN	*)	-	-	-	-	*	-
en_1080.txt	0	13	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	14	individuals	NNS	(NP(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	15	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	16	European	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	17	ancestry	NN	*)))	-	-	-	-	*	-
en_1080.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	19	more	JJR	(NP(NP(QP*	-	-	-	-	*	-
en_1080.txt	0	20	than	IN	*	-	-	-	-	*	-
en_1080.txt	0	21	50	CD	*)	-	-	-	-	*	-
en_1080.txt	0	22	%	NN	*)	-	-	-	-	*	-
en_1080.txt	0	23	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	24	those	DT	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	25	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	26	Asian	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	27	ancestry	NN	*)))))))))))	-	-	-	-	*	-
en_1080.txt	0	28	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1080.txt	0	1	many	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	2	such	JJ	*	-	-	-	-	*	-
en_1080.txt	0	3	patients	NNS	*))	-	-	-	-	*	-
en_1080.txt	0	4	,	,	*	-	-	-	-	*	-
en_1080.txt	0	5	doubling	VBG	(S(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	6	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	7	dose	NN	*)	-	-	-	-	*	-
en_1080.txt	0	8	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	9	Plavix	NNP	(NP*))))	-	-	-	-	*	(6)
en_1080.txt	0	10	,	,	*	-	-	-	-	*	-
en_1080.txt	0	11	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	12	checking	VBG	(VP*	-	-	-	-	*	-
en_1080.txt	0	13	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	14	platelet	JJ	*	-	-	-	-	*	-
en_1080.txt	0	15	function	NN	*)	-	-	-	-	*	-
en_1080.txt	0	16	with	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	17	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	18	point-of-care	JJ	*	-	-	-	-	*	-
en_1080.txt	0	19	test	NN	*)	-	-	-	-	*	-
en_1080.txt	0	20	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_1080.txt	0	21	assure	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	22	suppression	NN	(NP*))))))))))	-	-	-	-	*	-
en_1080.txt	0	23	,	,	*	-	-	-	-	*	-
en_1080.txt	0	24	can	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	25	override	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	26	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	27	lack	NN	*)	-	-	-	-	*	-
en_1080.txt	0	28	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	29	response	NN	(NP*)))))	-	-	-	-	*	-
en_1080.txt	0	30	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	There	EX	(TOP(S(NP*)	-	-	-	-	*	-
en_1080.txt	0	1	are	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	2	alternative	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	3	drugs	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	4	,	,	*	-	-	-	-	*	-
en_1080.txt	0	5	such	JJ	(PP*	-	-	-	-	*	-
en_1080.txt	0	6	as	IN	*	-	-	-	-	*	-
en_1080.txt	0	7	prasugrel	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	8	or	CC	*	-	-	-	-	*	-
en_1080.txt	0	9	ticagrelor	NN	*))	-	-	-	-	*	-
en_1080.txt	0	10	,	,	*	-	-	-	-	*	-
en_1080.txt	0	11	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	12	can	MD	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	13	be	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	14	used	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	15	instead	RB	(PP*	-	-	-	-	*	-
en_1080.txt	0	16	of	IN	*	-	-	-	-	*	-
en_1080.txt	0	17	Plavix	NNP	(NP*))	-	-	-	-	*	(6)
en_1080.txt	0	18	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	19	bypass	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	20	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	21	problem	NN	*)))))))))))	-	-	-	-	*	-
en_1080.txt	0	22	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	The	DT	(TOP(S(NP(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	1	story	NN	*)	-	-	-	-	*	-
en_1080.txt	0	2	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	3	interferon	NN	(NP*)))	-	-	-	-	*	-
en_1080.txt	0	4	,	,	*	-	-	-	-	*	-
en_1080.txt	0	5	given	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	7	one	CD	(NP*	-	-	-	-	*	-
en_1080.txt	0	8	year	NN	*))	-	-	-	-	*	-
en_1080.txt	0	9	to	TO	(PP*	-	-	-	-	*	-
en_1080.txt	0	10	patients	NNS	(NP*))	-	-	-	-	*	-
en_1080.txt	0	11	with	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	12	hepatitis	NNP	(NP*	-	-	-	-	*	-
en_1080.txt	0	13	C	NNP	*	-	-	-	-	*	-
en_1080.txt	0	14	virus	NN	*)))	-	-	-	-	*	-
en_1080.txt	0	15	,	,	*)	-	-	-	-	*	-
en_1080.txt	0	16	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	17	particularly	RB	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	18	striking	JJ	*))	-	-	-	-	*	-
en_1080.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	This	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1080.txt	0	1	treatment	NN	*)	-	-	-	-	*	-
en_1080.txt	0	2	is	VBZ	(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	3	very	RB	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	4	costly	JJ	*)	-	-	-	-	*	-
en_1080.txt	0	5	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1080.txt	0	6	about	IN	(NP(QP*	-	-	-	-	*	-
en_1080.txt	0	7	$	$	*	-	-	-	-	*	-
en_1080.txt	0	8	50,000	CD	*))	-	-	-	-	*	-
en_1080.txt	0	9	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1080.txt	0	10	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	11	makes	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	12	all	DT	(S(NP*	-	-	-	-	*	-
en_1080.txt	0	13	patients	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	14	feel	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	15	quite	RB	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	16	ill	JJ	*	-	-	-	-	*	-
en_1080.txt	0	17	with	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	18	flu-like	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	19	symptoms	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	20	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	21	general	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	22	malaise	NN	*))))))))	-	-	-	-	*	-
en_1080.txt	0	23	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	But	CC	(TOP(S*	-	-	-	-	*	-
en_1080.txt	0	1	the	DT	(NP*	-	-	-	-	*	(8
en_1080.txt	0	2	drug	NN	*)	-	-	-	-	*	8)
en_1080.txt	0	3	works	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	4	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	5	only	RB	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	6	half	NN	*)	-	-	-	-	*	-
en_1080.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	8	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	9	people	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	10	treated	VBN	(VP*))))))	-	-	-	-	*	-
en_1080.txt	0	11	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	We	PRP	(TOP(S(S(NP*)	-	-	-	-	*	-
en_1080.txt	0	1	now	RB	(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	2	know	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	3	that	IN	(SBAR*	-	-	-	-	*	-
en_1080.txt	0	4	a	DT	(S(NP*	-	-	-	-	*	-
en_1080.txt	0	5	simple	JJ	*	-	-	-	-	*	-
en_1080.txt	0	6	genotype	NN	*)	-	-	-	-	*	-
en_1080.txt	0	7	sorts	VBD	(VP*	-	-	-	-	*	-
en_1080.txt	0	8	out	RP	(PRT*)	-	-	-	-	*	-
en_1080.txt	0	9	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	10	will	MD	(S(VP(VP*)	-	-	-	-	*	-
en_1080.txt	0	11	or	CC	*	-	-	-	-	*	-
en_1080.txt	0	12	will	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	13	not	RB	*	-	-	-	-	*	-
en_1080.txt	0	14	benefit	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	15	from	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	16	interferon	NN	(NP*))))))))))))	-	-	-	-	*	-
en_1080.txt	0	17	,	,	*	-	-	-	-	*	-
en_1080.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	19	there	EX	(S(NP*)	-	-	-	-	*	-
en_1080.txt	0	20	are	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	21	many	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	22	new	JJ	*	-	-	-	-	*	-
en_1080.txt	0	23	drugs	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	24	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	25	development	NN	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	26	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	27	those	DT	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	28	who	WP	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	29	will	MD	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	30	not	RB	*))))))))))	-	-	-	-	*	-
en_1080.txt	0	31	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	The	DT	(TOP(S(NP*	-	-	-	-	*	-
en_1080.txt	0	1	list	NN	*)	-	-	-	-	*	-
en_1080.txt	0	2	goes	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	3	on	IN	(PP*))	-	-	-	-	*	-
en_1080.txt	0	4	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	For	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1080.txt	0	1	warfarin	NN	(NP*))	-	-	-	-	*	-
en_1080.txt	0	2	,	,	*	-	-	-	-	*	-
en_1080.txt	0	3	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	4	widely	RB	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	5	prescribed	VBN	*)	-	-	-	-	*	-
en_1080.txt	0	6	drug	NN	*)	-	-	-	-	*	-
en_1080.txt	0	7	used	VBD	(VP*	-	-	-	-	*	-
en_1080.txt	0	8	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	9	prevent	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	10	blood	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	11	clots	NNS	*))))	-	-	-	-	*	-
en_1080.txt	0	12	,	,	*	-	-	-	-	*	-
en_1080.txt	0	13	genotyping	VBG	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	14	can	MD	(SBAR(S(VP*	-	-	-	-	*	-
en_1080.txt	0	15	guide	VB	(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	16	the	DT	(NP*	-	-	-	-	*	(9
en_1080.txt	0	17	right	JJ	*	-	-	-	-	*	-
en_1080.txt	0	18	dose	NN	*))	-	-	-	-	*	9)
en_1080.txt	0	19	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	20	hasten	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	21	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	22	time	NN	*)	-	-	-	-	*	-
en_1080.txt	0	23	it	PRP	(SBAR(S(NP*)	-	-	-	-	*	(9)
en_1080.txt	0	24	takes	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	25	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	26	get	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	27	to	TO	(PP*	-	-	-	-	*	-
en_1080.txt	0	28	steady	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	29	state	NN	*)))))))))))))))))	-	-	-	-	*	-
en_1080.txt	0	30	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Genotyping	NN	(TOP(S(NP*)	-	-	-	-	*	-
en_1080.txt	0	1	can	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	2	also	RB	(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	3	predict	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	4	severe	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	5	liver	NN	*	-	-	-	-	*	-
en_1080.txt	0	6	toxicity	NN	*)	-	-	-	-	*	-
en_1080.txt	0	7	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	8	drugs	NNS	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	9	such	JJ	(PP*	-	-	-	-	*	-
en_1080.txt	0	10	as	IN	*	-	-	-	-	*	-
en_1080.txt	0	11	flucloxacillin	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	12	or	CC	*	-	-	-	-	*	-
en_1080.txt	0	13	lumiricoxib	NN	*)))))))	-	-	-	-	*	-
en_1080.txt	0	14	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	To	TO	(TOP(S(S(VP*	-	-	-	-	*	-
en_1080.txt	0	1	be	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	2	sure	JJ	(ADJP*))))	-	-	-	-	*	-
en_1080.txt	0	3	,	,	*	-	-	-	-	*	-
en_1080.txt	0	4	our	PRP$	(NP*	-	-	-	-	*	(10)
en_1080.txt	0	5	predictive	JJ	*	-	-	-	-	*	-
en_1080.txt	0	6	ability	NN	*)	-	-	-	-	*	-
en_1080.txt	0	7	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	8	far	RB	(ADVP*	-	-	-	-	*	-
en_1080.txt	0	9	from	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	10	complete	JJ	(ADJP*))))	-	-	-	-	*	-
en_1080.txt	0	11	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	We	PRP	(TOP(S(NP*)	-	-	-	-	*	(10)
en_1080.txt	0	1	know	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	2	only	JJ	(SBAR(S(NP*	-	-	-	-	*	-
en_1080.txt	0	3	common	JJ	*	-	-	-	-	*	-
en_1080.txt	0	4	gene	NN	*)	-	-	-	-	*	-
en_1080.txt	0	5	variants	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	from	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	7	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	8	GWAS	NNP	*	-	-	-	-	*	-
en_1080.txt	0	9	approach	NN	*))))))	-	-	-	-	*	-
en_1080.txt	0	10	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Furthermore	RB	(TOP(S(S(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	1	,	,	*	-	-	-	-	*	-
en_1080.txt	0	2	most	JJS	(NP*	-	-	-	-	*	-
en_1080.txt	0	3	drugs	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	4	have	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	5	not	RB	*	-	-	-	-	*	-
en_1080.txt	0	6	even	RB	(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	7	been	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	8	studied	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	9	yet	RB	(ADVP*)))))	-	-	-	-	*	-
en_1080.txt	0	10	,	,	*	-	-	-	-	*	-
en_1080.txt	0	11	so	IN	*	-	-	-	-	*	-
en_1080.txt	0	12	there	EX	(S(NP*)	-	-	-	-	*	-
en_1080.txt	0	13	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	14	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	15	long	JJ	*	-	-	-	-	*	-
en_1080.txt	0	16	way	NN	*)	-	-	-	-	*	-
en_1080.txt	0	17	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_1080.txt	0	18	go	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	19	fill	NN	(NP*)	-	-	-	-	*	-
en_1080.txt	0	20	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	21	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	22	holes	NNS	*)))))))))	-	-	-	-	*	-
en_1080.txt	0	23	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Nevertheless	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	1	,	,	*	-	-	-	-	*	-
en_1080.txt	0	2	substantive	JJ	(NP(ADJP*	-	-	-	-	*	-
en_1080.txt	0	3	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	4	remarkable	JJ	*)	-	-	-	-	*	-
en_1080.txt	0	5	progress	NN	*)	-	-	-	-	*	-
en_1080.txt	0	6	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	7	been	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	8	made	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	9	,	,	*	-	-	-	-	*	-
en_1080.txt	0	10	all	DT	(PP(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	11	in	IN	*	-	-	-	-	*	-
en_1080.txt	0	12	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	13	last	JJ	*	-	-	-	-	*	-
en_1080.txt	0	14	few	JJ	*	-	-	-	-	*	-
en_1080.txt	0	15	years	NNS	*)))))	-	-	-	-	*	-
en_1080.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Moreover	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	1	,	,	*	-	-	-	-	*	-
en_1080.txt	0	2	someday	RB	(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	3	we	PRP	(NP*)	-	-	-	-	*	(10)
en_1080.txt	0	4	will	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	5	know	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	7	via	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	8	sequencing	VBG	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	10	the	DT	(NP*	-	-	-	-	*	(2
en_1080.txt	0	11	whole	JJ	*	-	-	-	-	*	-
en_1080.txt	0	12	genome	NN	*))	-	-	-	-	*	2)
en_1080.txt	0	13	–	SYM	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	14	about	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	15	rarer	JJR	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	16	genomic	NN	*	-	-	-	-	*	-
en_1080.txt	0	17	variations	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	18	that	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	19	are	VBP	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	20	correlated	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	21	with	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	22	treatment	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	23	response	NN	*	-	-	-	-	*	-
en_1080.txt	0	24	or	CC	*	-	-	-	-	*	-
en_1080.txt	0	25	side-effects	NNS	*)))))))))))))))	-	-	-	-	*	-
en_1080.txt	0	26	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	This	DT	(TOP(S(NP*)	-	-	-	-	*	-
en_1080.txt	0	1	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	2	paved	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	3	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	4	way	NN	*)	-	-	-	-	*	-
en_1080.txt	0	5	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	6	next-generation	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	7	pharmacies	NNS	*)))))	-	-	-	-	*	-
en_1080.txt	0	8	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Genotyping	NN	(TOP(S(NP*)	-	-	-	-	*	-
en_1080.txt	0	1	can	MD	(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	2	now	RB	(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	3	be	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	4	accomplished	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	5	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	6	20	CD	(NP*	-	-	-	-	*	-
en_1080.txt	0	7	minutes	NNS	*)))))	-	-	-	-	*	-
en_1080.txt	0	8	,	,	*	-	-	-	-	*	-
en_1080.txt	0	9	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	10	over	IN	(VP(PP*	-	-	-	-	*	-
en_1080.txt	0	11	time	NN	(NP*))	-	-	-	-	*	-
en_1080.txt	0	12	will	MD	*	-	-	-	-	*	-
en_1080.txt	0	13	get	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	14	even	RB	(ADVP*	-	-	-	-	*	-
en_1080.txt	0	15	faster	RBR	*))))	-	-	-	-	*	-
en_1080.txt	0	16	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	To	TO	(TOP(S(S(VP*	-	-	-	-	*	-
en_1080.txt	0	1	fill	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	2	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	3	prescription	NN	*)	-	-	-	-	*	-
en_1080.txt	0	4	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	5	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	6	drug	NN	*)	-	-	-	-	*	-
en_1080.txt	0	7	with	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	8	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	9	known	VBN	*	-	-	-	-	*	-
en_1080.txt	0	10	pharmacogenomic	NN	*	-	-	-	-	*	-
en_1080.txt	0	11	profile	NN	*))))))))	-	-	-	-	*	-
en_1080.txt	0	12	,	,	*	-	-	-	-	*	-
en_1080.txt	0	13	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	14	customer	NN	*)	-	-	-	-	*	-
en_1080.txt	0	15	can	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	16	get	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	17	rapid	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	18	genotyping	NN	*)	-	-	-	-	*	-
en_1080.txt	0	19	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	20	determine	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	21	appropriate	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	22	dose	NN	*	-	-	-	-	*	-
en_1080.txt	0	23	,	,	*	-	-	-	-	*	-
en_1080.txt	0	24	drug	NN	*	-	-	-	-	*	-
en_1080.txt	0	25	,	,	*	-	-	-	-	*	-
en_1080.txt	0	26	or	CC	*	-	-	-	-	*	-
en_1080.txt	0	27	predilection	NN	*)	-	-	-	-	*	-
en_1080.txt	0	28	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	29	serious	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	30	side-effects	NNS	*))))))))	-	-	-	-	*	-
en_1080.txt	0	31	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Or	CC	(TOP(S*	-	-	-	-	*	-
en_1080.txt	0	1	even	RB	(ADJP*	-	-	-	-	*	-
en_1080.txt	0	2	better	JJR	*)	-	-	-	-	*	-
en_1080.txt	0	3	,	,	*	-	-	-	-	*	-
en_1080.txt	0	4	many	JJ	(NP*	-	-	-	-	*	(11
en_1080.txt	0	5	people	NNS	*)	-	-	-	-	*	11)
en_1080.txt	0	6	will	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	7	submit	VB	(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	8	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	9	saliva	JJ	*	-	-	-	-	*	-
en_1080.txt	0	10	sample	NN	*)	-	-	-	-	*	-
en_1080.txt	0	11	to	TO	(PP*	-	-	-	-	*	-
en_1080.txt	0	12	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	13	consumer	NN	*	-	-	-	-	*	-
en_1080.txt	0	14	genomics	NNS	*	-	-	-	-	*	-
en_1080.txt	0	15	company	NN	*)	-	-	-	-	*	-
en_1080.txt	0	16	,	,	*	-	-	-	-	*	-
en_1080.txt	0	17	which	WDT	(SBAR(WHNP*)	-	-	-	-	*	-
en_1080.txt	0	18	will	MD	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	19	analyze	VB	(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	20	all	DT	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	21	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	22	their	PRP$	(NP*	-	-	-	-	*	(12|(11)
en_1080.txt	0	23	pharmacogenomic	JJ	*	-	-	-	-	*	-
en_1080.txt	0	24	data	NNS	*))))	-	-	-	-	*	12)
en_1080.txt	0	25	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	26	perform	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	27	an	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	28	extensive	JJ	*	-	-	-	-	*	-
en_1080.txt	0	29	panel	NN	*)	-	-	-	-	*	-
en_1080.txt	0	30	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	31	genotypes	NNS	(NP*))	-	-	-	-	*	-
en_1080.txt	0	32	,	,	*	-	-	-	-	*	-
en_1080.txt	0	33	updated	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	34	every	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	35	month	NN	*))))))))	-	-	-	-	*	-
en_1080.txt	0	36	,	,	*)))	-	-	-	-	*	-
en_1080.txt	0	37	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	38	store	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	39	the	DT	(NP*	-	-	-	-	*	(12
en_1080.txt	0	40	data	NNS	*)	-	-	-	-	*	12)
en_1080.txt	0	41	on	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	42	their	PRP$	(NP*	-	-	-	-	*	(11)
en_1080.txt	0	43	smart	JJ	*	-	-	-	-	*	-
en_1080.txt	0	44	phones	NNS	*)))))	-	-	-	-	*	-
en_1080.txt	0	45	.	.	*	-	-	-	-	*	-
en_1080.txt	0	46	For	IN	(S(PP*	-	-	-	-	*	-
en_1080.txt	0	47	mail-order	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	48	prescriptions	NNS	*))	-	-	-	-	*	-
en_1080.txt	0	49	,	,	*	-	-	-	-	*	-
en_1080.txt	0	50	such	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	51	genomic	JJ	*	-	-	-	-	*	-
en_1080.txt	0	52	data	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	53	would	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	54	be	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	55	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	56	routine	JJ	*	-	-	-	-	*	-
en_1080.txt	0	57	part	NN	*)	-	-	-	-	*	-
en_1080.txt	0	58	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	59	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	60	customer	NN	*	-	-	-	-	*	-
en_1080.txt	0	61	database	NN	*))))))	-	-	-	-	*	-
en_1080.txt	0	62	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	In	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1080.txt	0	1	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	2	United	NNP	*	-	-	-	-	*	-
en_1080.txt	0	3	States	NNP	*))	-	-	-	-	*	-
en_1080.txt	0	4	,	,	*	-	-	-	-	*	-
en_1080.txt	0	5	pharmacy	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	6	benefit	NN	*	-	-	-	-	*	-
en_1080.txt	0	7	managers	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	8	-LRB-	-LRB-	(PRN*	-	-	-	-	*	-
en_1080.txt	0	9	PBM	NNP	(NP*)	-	-	-	-	*	-
en_1080.txt	0	10	-RRB-	-RRB-	*))	-	-	-	-	*	-
en_1080.txt	0	11	handle	VBP	(VP(VP*	-	-	-	-	*	-
en_1080.txt	0	12	prescriptions	NNS	(NP*)	-	-	-	-	*	-
en_1080.txt	0	13	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	14	almost	RB	(NP*	-	-	-	-	*	-
en_1080.txt	0	15	all	DT	*	-	-	-	-	*	-
en_1080.txt	0	16	large	JJ	*	-	-	-	-	*	-
en_1080.txt	0	17	employers	NNS	*)))	-	-	-	-	*	-
en_1080.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	19	account	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	20	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	21	more	JJR	(NP(QP*	-	-	-	-	*	-
en_1080.txt	0	22	than	IN	*	-	-	-	-	*	-
en_1080.txt	0	23	200	CD	*	-	-	-	-	*	-
en_1080.txt	0	24	million	CD	*)	-	-	-	-	*	-
en_1080.txt	0	25	individuals	NNS	*))))	-	-	-	-	*	-
en_1080.txt	0	26	.	.	*	-	-	-	-	*	-
en_1080.txt	0	27	Two	CD	(NP(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	28	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	29	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	30	largest	JJS	*	-	-	-	-	*	-
en_1080.txt	0	31	PBMs	NNS	*)))	-	-	-	-	*	-
en_1080.txt	0	32	,	,	*	-	-	-	-	*	-
en_1080.txt	0	33	Medco	NNP	(NP*	-	-	-	-	*	-
en_1080.txt	0	34	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	35	CVS	NNP	*	-	-	-	-	*	-
en_1080.txt	0	36	/	NNP	*	-	-	-	-	*	-
en_1080.txt	0	37	Caremark	NNP	*)	-	-	-	-	*	-
en_1080.txt	0	38	,	,	*)	-	-	-	-	*	-
en_1080.txt	0	39	have	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	40	announced	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	41	plans	NNS	(NP*	-	-	-	-	*	-
en_1080.txt	0	42	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	43	conduct	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	44	large-scale	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	45	genotyping	NN	*)	-	-	-	-	*	-
en_1080.txt	0	46	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	47	many	JJ	(NP*	-	-	-	-	*	(13
en_1080.txt	0	48	drugs	NNS	*))))))))	-	-	-	-	*	13)
en_1080.txt	0	49	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Their	PRP$	(TOP(S(NP*	-	-	-	-	*	(13)
en_1080.txt	0	1	motives	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	2	include	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	3	more	RBR	(NP(NP(ADJP*	-	-	-	-	*	-
en_1080.txt	0	4	efficient	JJ	*)	-	-	-	-	*	-
en_1080.txt	0	5	use	NN	*)	-	-	-	-	*	-
en_1080.txt	0	6	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	7	prescription	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	8	drugs	NNS	*))	-	-	-	-	*	-
en_1080.txt	0	9	,	,	*	-	-	-	-	*	-
en_1080.txt	0	10	along	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	11	with	IN	*	-	-	-	-	*	-
en_1080.txt	0	12	getting	VBG	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	13	an	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	14	edge	NN	*)	-	-	-	-	*	-
en_1080.txt	0	15	on	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	16	other	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	17	PBM	NNP	*	-	-	-	-	*	-
en_1080.txt	0	18	competitors	NNS	*)))))))	-	-	-	-	*	-
en_1080.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	With	IN	(TOP(S(PP*	-	-	-	-	*	-
en_1080.txt	0	1	annual	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	2	expenditures	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	3	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	4	prescription	NN	(NP*	-	-	-	-	*	-
en_1080.txt	0	5	drugs	NNS	*))	-	-	-	-	*	-
en_1080.txt	0	6	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	7	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	8	US	NNP	*))	-	-	-	-	*	-
en_1080.txt	0	9	totaling	VBG	(VP*	-	-	-	-	*	-
en_1080.txt	0	10	$	$	(NP(QP*	-	-	-	-	*	-
en_1080.txt	0	11	300	CD	*	-	-	-	-	*	-
en_1080.txt	0	12	billion	CD	*)))))	-	-	-	-	*	-
en_1080.txt	0	13	,	,	*	-	-	-	-	*	-
en_1080.txt	0	14	there	EX	(NP*)	-	-	-	-	*	-
en_1080.txt	0	15	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	16	certainly	RB	(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	17	room	NN	(NP(NP*)	-	-	-	-	*	-
en_1080.txt	0	18	to	TO	(SBAR(S(VP*	-	-	-	-	*	-
en_1080.txt	0	19	cut	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	20	costs	NNS	(NP*)))))))	-	-	-	-	*	-
en_1080.txt	0	21	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Unfortunately	RB	(TOP(S(ADVP*)	-	-	-	-	*	-
en_1080.txt	0	1	,	,	*	-	-	-	-	*	-
en_1080.txt	0	2	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	3	medical	JJ	*	-	-	-	-	*	-
en_1080.txt	0	4	community	NN	*)	-	-	-	-	*	-
en_1080.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	resisting	VBG	(VP*	-	-	-	-	*	-
en_1080.txt	0	7	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	8	use	NN	*)	-	-	-	-	*	-
en_1080.txt	0	9	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	10	pharmacogenomic	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	11	data	NNS	*)))	-	-	-	-	*	-
en_1080.txt	0	12	in	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	13	clinical	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	14	practice	NN	*))	-	-	-	-	*	-
en_1080.txt	0	15	,	,	*	-	-	-	-	*	-
en_1080.txt	0	16	despite	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	17	regulatory	JJ	(NP(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	18	authorities	NNS	*	-	-	-	-	*	-
en_1080.txt	0	19	'	POS	*)	-	-	-	-	*	-
en_1080.txt	0	20	recommendations	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	21	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	22	many	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	23	drugs	NNS	*))))))	-	-	-	-	*	-
en_1080.txt	0	24	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	PBMs	NNS	(TOP(S(NP*	-	-	-	-	*	-
en_1080.txt	0	1	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	2	consumer	NN	*	-	-	-	-	*	-
en_1080.txt	0	3	genomic	NN	*	-	-	-	-	*	-
en_1080.txt	0	4	companies	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	5	can	MD	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	be	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	7	a	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	8	positive	JJ	*	-	-	-	-	*	-
en_1080.txt	0	9	force	NN	*)	-	-	-	-	*	-
en_1080.txt	0	10	by	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	11	facilitating	VBG	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	12	or	CC	*	-	-	-	-	*	-
en_1080.txt	0	13	advancing	VBG	*	-	-	-	-	*	-
en_1080.txt	0	14	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	15	use	NN	*)	-	-	-	-	*	-
en_1080.txt	0	16	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	17	such	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	18	data	NNS	*))))))))	-	-	-	-	*	-
en_1080.txt	0	19	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	The	DT	(TOP(S(NP(NP*	-	-	-	-	*	(14
en_1080.txt	0	1	ultimate	JJ	*	-	-	-	-	*	-
en_1080.txt	0	2	goal	NN	*)	-	-	-	-	*	-
en_1080.txt	0	3	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	4	pharmacogenomics	NNS	(NP*)))	-	-	-	-	*	14)
en_1080.txt	0	5	is	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	6	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	7	provide	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	8	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	9	right	JJ	*	-	-	-	-	*	-
en_1080.txt	0	10	drug	NN	*)	-	-	-	-	*	-
en_1080.txt	0	11	,	,	*	-	-	-	-	*	-
en_1080.txt	0	12	at	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	13	the	DT	(NP*	-	-	-	-	*	(9
en_1080.txt	0	14	right	JJ	*	-	-	-	-	*	-
en_1080.txt	0	15	dose	NN	*))	-	-	-	-	*	9)
en_1080.txt	0	16	,	,	*	-	-	-	-	*	-
en_1080.txt	0	17	for	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	18	the	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	19	right	JJ	*	-	-	-	-	*	-
en_1080.txt	0	20	individual	NN	*))	-	-	-	-	*	-
en_1080.txt	0	21	,	,	*	-	-	-	-	*	-
en_1080.txt	0	22	without	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	23	any	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	24	significant	JJ	*	-	-	-	-	*	-
en_1080.txt	0	25	side-effects	NNS	*))))))	-	-	-	-	*	-
en_1080.txt	0	26	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Despite	IN	(TOP(S(S(PP*	-	-	-	-	*	-
en_1080.txt	0	1	widespread	JJ	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	2	misperceptions	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	3	about	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	4	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	5	practical	JJ	*	-	-	-	-	*	-
en_1080.txt	0	6	impact	NN	*)	-	-	-	-	*	-
en_1080.txt	0	7	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	8	genomic	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	9	research	NN	*))))))	-	-	-	-	*	-
en_1080.txt	0	10	,	,	*	-	-	-	-	*	-
en_1080.txt	0	11	the	DT	(NP*	-	-	-	-	*	(15
en_1080.txt	0	12	science	NN	*)	-	-	-	-	*	15)
en_1080.txt	0	13	has	VBZ	(VP*	-	-	-	-	*	-
en_1080.txt	0	14	hit	VBN	(VP*	-	-	-	-	*	-
en_1080.txt	0	15	its	PRP$	(NP*	-	-	-	-	*	(15)
en_1080.txt	0	16	stride	NN	*))))	-	-	-	-	*	-
en_1080.txt	0	17	,	,	*	-	-	-	-	*	-
en_1080.txt	0	18	and	CC	*	-	-	-	-	*	-
en_1080.txt	0	19	we	PRP	(S(NP*)	-	-	-	-	*	(16)
en_1080.txt	0	20	need	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	21	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	22	capitalize	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	23	on	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	24	this	DT	(NP*	-	-	-	-	*	-
en_1080.txt	0	25	momentum	NN	*))	-	-	-	-	*	-
en_1080.txt	0	26	if	IN	(SBAR*	-	-	-	-	*	-
en_1080.txt	0	27	we	PRP	(S(NP*)	-	-	-	-	*	(16)
en_1080.txt	0	28	are	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	29	to	TO	(S(VP*	-	-	-	-	*	-
en_1080.txt	0	30	realize	VB	(VP*	-	-	-	-	*	-
en_1080.txt	0	31	the	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	32	opportunity	NN	*)	-	-	-	-	*	-
en_1080.txt	0	33	of	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	34	individualized	JJ	(NP*	-	-	-	-	*	-
en_1080.txt	0	35	medicine	NN	*))))))))))))))	-	-	-	-	*	-
en_1080.txt	0	36	.	.	*))	-	-	-	-	*	-

en_1080.txt	0	0	Next-generation	JJ	(TOP(S(NP*	-	-	-	-	*	-
en_1080.txt	0	1	pharmacies	NNS	*)	-	-	-	-	*	-
en_1080.txt	0	2	represent	VBP	(VP*	-	-	-	-	*	-
en_1080.txt	0	3	a	DT	(NP(NP*	-	-	-	-	*	-
en_1080.txt	0	4	promising	JJ	*	-	-	-	-	*	-
en_1080.txt	0	5	step	NN	*)	-	-	-	-	*	-
en_1080.txt	0	6	toward	IN	(PP*	-	-	-	-	*	-
en_1080.txt	0	7	that	DT	(NP*	-	-	-	-	*	(14
en_1080.txt	0	8	goal	NN	*))))	-	-	-	-	*	14)
en_1080.txt	0	9	.	.	*))	-	-	-	-	*	-

#end document
